The short version
Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 0.6% of the time — roughly 4× the typical drug (0.1%).
Market view
ceftriaxone sodium · Injection, Solution
2 marketed package NDCs · 1 active manufacturer
Most dispensed: 1 g · Injection, Powder, For Solution · #10 vial, single-uses/carton / 1 injection, powder, for solution in 1 vial, single-use · 500 mg · Injection, Powder, For Solution · #10 vial, single-uses/carton / 1 injection, powder, for solution in 1 vial, single-use · 250 mg · Injection, Powder, For Solution · #10 vial, single-uses/carton / 1 injection, powder, for solution in 1 vial, single-use · 2 g · Injection, Powder, For Solution · #10 vial, single-uses/carton / 1 injection, powder, for solution in 1 vial, single-use
What changed in the last 90 days
Every detected change for ceftriaxone sodium, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Ceftriaxone SodiumAug 19, 2026Price upNADAC $1.78589 → $1.80756 per unit (+1.21%)
- Ceftriaxone SodiumAug 19, 2026Price upNADAC $1.24402 → $1.29761 per unit (+4.31%)
- Ceftriaxone SodiumAug 19, 2026Price upNADAC $2.65476 → $2.7 per unit (+1.7%)
- Ceftriaxone SodiumAug 19, 2026Price downNADAC $1.22566 → $1.19543 per unit (-2.47%)
- Ceftriaxone SodiumAug 19, 2026Price upNADAC $2.65476 → $2.7 per unit (+1.7%)
- Ceftriaxone SodiumAug 19, 2026Price downNADAC $1.22566 → $1.19543 per unit (-2.47%)
- Ceftriaxone SodiumAug 19, 2026Price upNADAC $1.24402 → $1.29761 per unit (+4.31%)
- Ceftriaxone SodiumAug 19, 2026Price upNADAC $1.78589 → $1.80756 per unit (+1.21%)
- Ceftriaxone SodiumAug 19, 2026Price upNADAC $1.24402 → $1.29761 per unit (+4.31%)
- Ceftriaxone SodiumAug 19, 2026Price upNADAC $1.24402 → $1.29761 per unit (+4.31%)
Same drug class
Other molecules FDA puts in Cephalosporin Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- cefotaxime· in shortage
- cefotaxime injection· in shortage
- ceftazidime, avibactam· 1 maker
- ceftobiprole medocaril sodium· 1 maker
- ceftolozane and tazobactam· 1 maker
- cefuroxime· 1 maker
- cefuroxime and dextrose· 1 maker
- zidebactam dihydrate and cefepime hydrochloride· 1 maker
- cefiderocol sulfate tosylate· 2 makers
- cefotetan· 2 makers
- cefotetan disodium· 2 makers
- ceftaroline fosamil· 2 makers
Common questions
- Is Ceftriaxone sodium in shortage right now?
- No. FDA does not currently list Ceftriaxone sodium in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Ceftriaxone sodium?
- 11 companies have marketed Ceftriaxone sodium in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Ceftriaxone sodium cost?
- The typical pharmacy pays about $1.30 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.